Submitted:
06 June 2023
Posted:
07 June 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Design of Animal Groups and Experiment
2.2. AgNOR Staining
2.3. Image Analysis of TAA/TNA Ratio and Mean AgNOR Number of Brain Cells
2.4. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Funding:
Author Contributions
Conflict of Interest
References
- Saritas A, Gunes H, Colakoglu S, Eroz R, Akoz A, Oktay M, Buyukkaya A, Kandis H, Ozkan A. Are there any effects of chronic carbon monoxide exposure on argyrophilic nucleolar-organizing region–associated protein synthesis in rat myocardium? Hum Exp Toxicol. 2016;35(9):921–928. [CrossRef]
- Raaijmakers NJ, Bokma AHF, Eggen GG, Prins G, Alsma J. An unhealthy blush - secondary erythrocytosis due to waterpipe smoking. Neth J Med. 2020;78(4):202-205.
- Al-Moamary MS, Al-Shammary AS, Al-Shimemeri AA, Ali MM, Al-Jahdali HH, Awada AA. Complications of carbon monoxide poisoning. Saudi Med J. 2000;21:361–3.
- Kim SG, Woo J, Kang GW. A case report on the acute and late complications associated with carbon monoxide poisoning: Acute kidney injury, rhabdomyolysis, and delayed leukoencephalopathy. Medicine (Baltimore). 2019;98(19):e15551.
- Gunes H, Saritas A, Eroz R, Colakoglu S. Use of argyrophilic nucleolar–organizer region-associated protein synthesis in skeletal muscle cells for prediction of chronic carbon monoxide exposure. Toxin Reviews. 2020;39:349-354. [CrossRef]
- Dorey A, Scheerlinck P, Nguyen H, Albertson T. Acute and Chronic Carbon Monoxide Toxicity from Tobacco Smoking. Military Medicine. 2020;185(1-2):e61–e67. [CrossRef]
- Katirci Y, Kandis H, Aslan S, Kirpinar I. Neuropsychiatric disorders and risk factors in carbon monoxide intoxication. Toxicol Ind Health. 2011;27(5):397-406. [CrossRef]
- Karagun E, Eroz R. Argyrophilic nucleolar organizing regions in patients with Xeroderma Pigmentosum Group E. Exp Dermatol. 2021 Mar;30(3):416-417. doi: 10.1111/exd.14238. Epub 2020 Nov 27. PMID: 33200418. [CrossRef]
- Kabaklıoğlu M, Eroz R, Kaya M. May Argyrophilic Nucleolar Organizer Regions Be Used as a Biomarker for the Detection of the Degree of Ischemic Damage Instead of Tunel in Testicular Torsion? Medicina (Kaunas). 2021 Oct 29;57(11):1177. doi: 10.3390/medicina57111177. PMID: 34833395; PMCID: PMC8619308. [CrossRef]
- Yesildag K, Kokulu K, Mutlu H et al. Argyrophilic nucleolar organizer regions as a promising biomarker for the detection of brain hypoxia levels caused by different doses of carbon monoxide poisoning. Gac Med Mex. 2021;157(6):610-617. English. doi: 10.24875/GMM.M21000625. PMID: 35108251. [CrossRef]
- Kaya M, Eroz R, Kabakliogli M. Expression of nucleolin, nucleophosmin, upstream binding transcription factor genes and propolis in wound models. J Wound Care. 2022 Oct 1;31(Sup10):S28-S40. doi: 10.12968/jowc.2022.31.Sup10.S28. PMID: 36240873. [CrossRef]
- Damar İH, Eroz R. Argyrophilic Nucleolar Organizer Regions as New Biomarkers in ST-Elevation Myocardial Infarction. J Cardiovasc Dev Dis. 2022 Feb 14;9(2):58. doi: 10.3390/jcdd9020058. PMID: 35200711; PMCID: PMC8875583. [CrossRef]
- Turan Sönmez F, Eröz R. The role of argyrophilic nucleolar organizing region-associated proteins in clinical exacerbation of chronic obstructive pulmonary disease. J Int Med Res. 2018 Dec;46(12):4995-5003. doi: 10.1177/0300060518788751. Epub 2018 Aug 8. PMID: 30088791; PMCID: PMC6300929. [CrossRef]
- Tasdemir S, Eroz R, Cucer N et al. Comparison of fine needle aspiration biopsy and paraffin embedded tissue sections for measuring AgNOR proteins. Biotech Histochem. 2015 Jul;90(5):395-9. doi: 10.3109/10520295.2015.1013989. Epub 2015 Apr 6. PMID: 25843622. [CrossRef]
- Nisari M, Eroz R, Nisari M et al. Investigation of argyrophilic nucleolar organizing region. Bratisl Lek Listy. 2016;117(6):345-50. doi: 10.4149/bll_2016_068. PMID: 27546367. [CrossRef]
- Eroz R, Tasdemir S, Dogan H. Is there any relationship between decreased AgNOR protein synthesis and human hair loss? Biotech Histochem. 2012 Nov;87(8):494-8. doi: 10.3109/10520295.2012.698307. Epub 2012 Jul 2. PMID: 22747173. [CrossRef]
- Tasdemir S, Eroz R, Dogan H et al. Association Between Human Hair Loss and the Expression Levels of Nucleolin, Nucleophosmin, and UBTF Genes. Genet Test Mol Biomarkers. 2016 Apr;20(4):197-202. doi: 10.1089/gtmb.2015.0246. Epub 2016 Feb 11. PMID: 26866305. [CrossRef]
- Selvi B, Demirtas H, Eroz R et al. Reduction of the argyrophilic nucleolar organizing region associated protein synthesis with age in buccal epithelial cells of healthy individuals. Aging Clin Exp Res. 2015 Apr;27(2):201-8. doi: 10.1007/s40520-014-0263-6. Epub 2014 Aug 1. PMID: 25082567. [CrossRef]
- Eroz R, Okur M, Ozkan A et al. Does higher NORs expression affect the developmental stages of Down syndrome infants? Genet Couns. 2012;23(2):249-53. PMID: 22876584.
- Eroz R, Cucer N, Unluhizarci K et al. Tiroid papiller karsinom ve normal tiroid hücre çekirdeklerinde AgNOR sayısının değerlendirilmesi. Erciyes Üniversitesi Sağlık Bilimleri Dergisi (Journal of health sciences). 2010;102-107. https://dergipark.org.tr/tr/pub/eujhs/issue/44542/552470.
- Ertekin T, Bozkurt O, Eroz R et al. May argyrophilic nucleolar organizing region-associated protein synthesis be used for selecting the most reliable dose of drugs such as rhamnetin in cancer treatments? Bratisl Med Jour. 2016;117 (11): 653-658. [CrossRef]
- Nisari M, Yilmaz S, Eroz R et al. The detection of curcumins' antitumoral effects via argyrophilic nucleolar organizing region-associated protein synthesis in mice with Ehrlich's ascitic carcinoma. Bratisl Med Jour. 2017; 118(1):61-65. [CrossRef]
- Nisari M, Eroz R. Does capsaicin have therapeutic benefits in human colon adenocarcinoma? Selection of the most reliable dose via AgNOR. Turk J Med Sci. 2020;3;50(4):1076-81. [CrossRef]
- Çolakoğlu S, Saritas A, Eroz R, Oktay M, Yaykasli KO, Akoz A, Kaya E, Kandis H. Is one-time carbon monoxide intoxication harmless? Evaluation by argyrophilic nucleolar-organizing regions staining method. Hum Exp Toxicol. 2015;34(1):24-31. [CrossRef]
- Kandiş H, Afacan MA, Eröz R, Colakoglu S, Bayramoglu A, Oktay M, Saritas A, Colak S, Kaya M, Kara İH. Can argyrophilic nucleolar organizing region-associated protein amount be used for the detection of cardiac damage? Hum Exp Toxicol 2015;35: 323-331. [CrossRef]
- Eroz R, Saritas A, Colakoglu S, Oktay M, Kandis H. Evaluation of argyrophilic nucleolar organizing region–associated protein synthesis in femoral muscle cells of rats exposed 3000 ppm carbon monoxide gas. Konuralp Medical Journal. 2016;8: 9-13.
- Yesildag K, Kokulu K, Mutlu H, Eroz R, Taha-Sert E, Saritas A. Argyrophilic nucleolar organizer regions as a promising biomarker for the detection of brain hypoxia levels caused by different doses of carbon monoxide poisoning. Gac Med Mex. 2021;157(6):610-617. English. doi: 10.24875/GMM.M21000625. PMID: 35108251. [CrossRef]
- Benn PA, Perle M. Chromosome staining and banding techniques In: Rooney DE, Czepulkowski BH. (eds). Human Cytogenetics, Constitutional Analysis, practical approach, Vol 1 Oxford: Oxford University Press, 1986; p.91–118.
- Lindner LE. Improvements in the silver-staining technique for nucleolar organizer regions (AgNOR). Journal of histochemistry and cytochemistry 1993; 41(3):439–445. [CrossRef]
- Imamoglu N, Eroz R, Canatan H, Demirtas H and Saatci C. Nuclear AgNOR Protein Enhancement in Nucleoplasms of Peripheral Blood Lymphocytes of Babies/Children With Down Syndrome. Microsc Res Tech. 2016;79(3):133-9. [CrossRef]
- Rasband WS (1997–2016) ImageJ U. S. National Institutes of Health. Bethesda. Maryland. USA. https://imagej.nih.gov/ij/.
- Kandis H, Katırcı Y, Cakır Z, Aslan S, Uzkeser M, Bilir O. A retrospective analyze of the patients admitted to emergency service for carbon monoxide intoxication. Eurasian J Emerg Med. 2007;6(3):21-25.
- Myers RA, DeFazio A, Kelly MP. Chronic carbon monoxide exposure: a clinical syndrome detected by neuropsychological tests. J Clin Psychol. 1998;54(5):555-67.
- Heckerling PS. Occult carbon monoxide poisoning: a cause of winter headache. Am J Emerg Med. 1987;5:201–204. [CrossRef]
- Kobyakov D, Klimachev V, Avdalyan A, Bobrov I, Bychkova E, Kruglova N, Lazarev A, Lushnikova E, Nepomnyashchikh L. Association between Argyrophilic Proteins of Nucleolar Organizer Regions, Clinicomorphological Parameters, and Survival in Non-Small-Cell Lung Cancer. Lung Cancer Int. 2014;2014:891917. doi: 10.1155/2014/891917. Epub 2014 Jan 2. PMID: 26316948; PMCID: PMC4437406. [CrossRef]
- Bànkfalvi A, Ofner D, Schmid KW, Schmitz KJ, Breukelmann D, Krech R, Böcker W. Standardized in situ AgNOR analysis in breast pathology: diagnostic and cell kinetic implications. Pathol Res Pract. 1999;195(4):219-29. doi: 10.1016/S0344-0338(99)80038-7. PMID: 10337659. [CrossRef]
- Slowinska-Klencka D, Klencki M, Popowicz B, et al. AgNOR quantification in the diagnosis of follicular pattern thyroid lesions. Analysis and Quantitaive Cytology and Histology 2003;25:347–352.
- Slowi’nska-Klencka D, Klencki M, Popowicz B, et al. Multiparameter analysis of AgNOR in thyroid lesions: comparison with PCNA expression. Histol Histopathol 2004;19:785–792. [CrossRef]


| Groups | Mean AgNOR Number ± SD (n=50) | Mean TAA/TNA ± SD (n=50) | Average AgNOR number of Groups / Median (Range) (n=300) | Average TAA/TNA of Groups / Median (Range) (n=300) | χ2 | p |
|---|---|---|---|---|---|---|
| Grp A1 | 1.44±0.644 | 0.061±0.016 | 1.428±0.073 / 1.402 (0.196) | 0.058±0.002 / 0.058 (0.005) | 12.051* 12.316& |
0.002* 0.002& |
| Grp A2 | 1.38±0.53 | 0.056±0.018 | ||||
| Grp A3 | 1.412±0.536 | 0.057±0.013 | ||||
| Grp A4 | 1.392±0.532 | 0.060±0.019 | ||||
| Grp A5 | 1.568±0.5 | 0.059±0.014 | ||||
| Grp A6 | 1.373±0.528 | 0.057±0.016 | ||||
| Grp B1 | 2.58±0.758 | 0.081±0.019 | 2.384±0.318 / 2.496(0.804) | 0.084±0.005 / 0.084 (0.012) | ||
| Grp B2 | 2.706±0.807 | 0.091±0.017 | ||||
| Grp B3 | 2.608±0.723 | 0.084±0.024 | ||||
| Grp B4 | 2,412±0.669 | 0.088±0.027 | ||||
| Grp B5 | 1.902±0.671 | 0.079±0.018 | ||||
| Grp B6 | 2.098±0.641 | 0.084±0.027 | ||||
| Grp C1 | 2.06±0.652 | 0.067±0.027 | 2.160±0.167 / 2.157 (0.490) | 0.088±0.011 / 0.090 (0.031) | ||
| Grp C2 | 1.922±0.688 | 0.089±0.015 | ||||
| Grp C3 | 2.255±0.796 | 0.099±0.016 | ||||
| Grp C4 | 2.412±0.804 | 0.092±0.023 | ||||
| Grp C5 | 2.157±0.579 | 0.091±0.024 | ||||
| Grp C6 | 2.157±0.731 | 0.091±0.016 |
| Groups | Grp A | Grp B | Grp C | |
|---|---|---|---|---|
| P | P | P | ||
| Grp A | - | 0.004 | 0.004 | |
| TAA/TNA ratio | Grp B | 0.004 | - | 0.150 |
| Grp C | 0.004 | 0.150 | - | |
| Grp A | - | 0.004 | 0.004 | |
| Mean AgNOR Number | Grp B | 0.004 | - | 0.228 |
| Grp C | 0.004 | 0.228 | - |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).